Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
73 hedge funds and large institutions have $665M invested in Taro Pharmaceutical Industries Ltd. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 11 closing their positions.
165% more call options, than puts
Call options by funds: $743K | Put options by funds: $280K
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
48% more capital invested
Capital invested by funds: $449M → $665M (+$216M)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more funds holding
Funds holding: 66 → 73 (+7)
16% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 25
Top Buyers
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$34.5M |
| 2 |
PA
Perceptive Advisors
New York
|
+$22.7M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$15.5M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$11.4M |
| 5 |
Renaissance Technologies
New York
|
+$11.4M |
Top Sellers
| 1 |
AIM
Assured Investment Management
New York
|
-$31.7M |
| 2 |
Morgan Stanley
New York
|
-$2.04M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$1.75M |
| 4 |
Barclays
London,
United Kingdom
|
-$1.75M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.27M |
TARO Hedge Fund Activity: Q2 2014 in Review
73 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2014, worth a combined $665M — up 48% from $449M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new TARO positions and 11 closed out — a net gain of 7 holders — while 21 added to existing stakes and 25 trimmed.
The largest buyer was Schroder Investment Management Group, opening a new position worth an estimated $34.5M. The largest seller was Assured Investment Management, cutting an estimated $31.7M.
- 73 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2014, up from 66 in Q1 2014.
- Funds reported $665M of Taro Pharmaceutical Industries Ltd. stock for Q2 2014, up 48% quarter-over-quarter.
- 18 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2014 and 11 closed out, a net change of +7 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2014 was Schroder Investment Management Group, an estimated $34.5M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2014 was Assured Investment Management, an estimated $31.7M sold.
Based on aggregated 13F filings for Q2 2014.